The future of fertility.
Juniper Genomics is shaping a better future for aspiring parents by enabling a faster, more successful IVF journey.
A new standard of care in PGT.
Genuine care means understanding more. Juniper offers the most complete, clinically relevant insights into embryo health so you can choose with confidence. Our simple two-step path grows with you, providing even more clarity when you’re ready for it.
For Patients
From first look to full picture
Many IVF journeys begin with chromosome testing. Juniper lets you go further. It’s the only test that starts with standard PGT-A and keeps the door open to deeper whole-genome insight when you’re ready.
Step 1: Clarity
PGT-A gives you an early look at embryo health by checking that each embryo has the correct number of chromosomes, a key factor in successful implantation and pregnancy.
Step 2: Insight
PGT-G goes far beyond chromosome counting. It examines nearly all of an embryo’s genetic code, uncovering variations linked to embryo viability, pregnancy success, and thousands of known genetic conditions.
Why families choose PGT-G
- Identify the embryos most likely to succeed – up to 85% live birth per transfer compared to 55% with standard chromosome testing.
- Decide, with your doctor, whether another IVF cycle may be needed – based on personalized data from your actual embryos, not average outcomes that you already know don’t always work for you.
- Check your embryo’s whole genome for genetic disease and pregnancy risks before transfer.
- Learn why a previous transfer may not have worked and what to do next.
Two steps. One clear path forward.
Juniper’s two-step approach gives you the flexibility to go deeper, learn more, and move forward with confidence.
For Clinicians
Advanced testing made simple
Juniper testing fits naturally into the way you already work. It’s simple to start every patient on PGT-A and expand to PGT-G only when needed. Because both tests run from a single biopsy, you can offer every patient a consistent experience, keep communication streamlined, and open the door to deeper insights later without disruption. It’s advanced genomics made practical, purposeful, and easy to adopt.
More answers after a failed transfer
When outcomes fall short, Juniper provides a data-driven way to understand why. PGT-G can reveal embryo-specific factors that traditional testing misses, helping you provide answers to grieving patients, refine protocols, and guide next steps with confidence.
Responsible care, grounded in science
Juniper’s multi-omic testing minimizes the chance of transferring embryos with serious genetic risks. It’s a proactive way to protect both patients and their future children while maintaining your standard of care.
Smarter family planning for every patient
Juniper data helps families plan more accurately: how many embryos they may need, how many cycles to expect, and which embryos to focus on.
Designed to support your clinical decisions
Use Juniper PGT-A for all your patients to keep the door open for advanced analysis later with Juniper’s PGT-G. Each case begins with standard chromosome insights and can expand to whole-genome clarity whenever needed.
Partner with us for your next IVF cycle.
Boosting IVF
Current euploid embryo testing is only 55% successful because it only uses a fraction of the data available from the embryo. Even embryos that test “normal” fail almost 50% of the time. It’s time to do better.
Backed by Experts
Our team is committed to advancing the future of IVF. We are supported by some of the brightest minds from the world’s most renowned institutions and respected funding agencies.
Responsible & Ethical
We empower fertility decisions with validated, scientific information that has a true impact on fertility success. We are committed to making that technology accessible to as many people as possible.
Testimonials
When you do good things, good people talk.
